Boston-area biotech pioneer on the ‘orphan drug revolution’


Jim Geraghty, longtime veteran of Genzyme and other Boston-area biotechs, wrote a book to "let people know that if we take this orphan-drug revolution for granted, it's not destined to continue on its own."

Previous Five things you need to know today, and the search for Moroccan fans
Next Kaleida's year-end loss prediction grows as expense and staffing challenges continue